Trials / Completed
CompletedNCT01345799
A Study of TRK-170 for the Treatment of Crohn's Disease
A Two Part, Multi-Centre, Randomized, Placebo-Controlled, Double-Blind Study of TRK-170 for the Treatment of Crohn's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- Toray Industries, Inc · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
In Crohn's Disease Patients * To evaluate the efficacy of TRK-170 * To evaluate the PK characteristics of TRK-170 * To assess the safety of TRK-170
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TRK-170 | |
| DRUG | Placebo |
Timeline
- Start date
- 2011-04-01
- Completion
- 2014-04-01
- First posted
- 2011-05-02
- Last updated
- 2014-06-12
Locations
13 sites across 13 countries: Belgium, Bulgaria, Czechia, France, Hungary, Latvia, Netherlands, Norway, Poland, Romania, Serbia, Sweden, Ukraine
Source: ClinicalTrials.gov record NCT01345799. Inclusion in this directory is not an endorsement.